| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.521 | 68.976 | 72.143 | 69.767 | 152.993 | 111.883 | 154.906 | 143.644 | 166.363 | 244.025 |
| Total Income - EUR | 27.521 | 68.976 | 72.143 | 69.767 | 152.993 | 112.456 | 199.202 | 169.885 | 178.231 | 250.670 |
| Total Expenses - EUR | 8.531 | 46.835 | 60.319 | 60.466 | 133.390 | 83.936 | 169.306 | 138.633 | 147.340 | 219.015 |
| Gross Profit/Loss - EUR | 18.990 | 22.141 | 11.824 | 9.301 | 19.603 | 28.521 | 29.896 | 31.252 | 30.890 | 31.656 |
| Net Profit/Loss - EUR | 18.154 | 20.681 | 11.131 | 8.436 | 18.053 | 27.378 | 28.055 | 29.300 | 29.417 | 26.480 |
| Employees | 0 | 2 | 0 | 3 | 3 | 3 | 5 | 4 | 3 | 3 |
Check the financial reports for the company - Maxendo Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 504 | 8.972 | 8.648 | 14.572 | 14.205 | 72.756 | 181.971 | 157.086 | 123.814 | 100.250 |
| Current Assets | 24.571 | 34.746 | 60.474 | 55.545 | 89.193 | 110.791 | 124.586 | 107.475 | 58.068 | 108.235 |
| Inventories | 9.252 | 12.025 | 31.809 | 17.592 | 20.344 | 43.085 | 70.729 | 67.338 | 20.313 | 60.778 |
| Receivables | 11.249 | 14.132 | 26.275 | 35.087 | 66.879 | 58.945 | 44.410 | 37.685 | 28.937 | 38.182 |
| Cash | 4.070 | 8.589 | 2.390 | 2.866 | 1.970 | 8.761 | 9.447 | 2.452 | 8.819 | 9.275 |
| Shareholders Funds | 18.199 | 38.695 | 49.171 | 46.557 | 63.741 | 86.259 | 98.019 | 59.242 | 11.762 | 32.755 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.876 | 5.023 | 19.950 | 23.560 | 39.658 | 97.288 | 93.016 | 115.681 | 92.621 | 115.362 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 115.521 | 89.638 | 77.499 | 70.420 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Maxendo Medica Srl